Clin2
NCT07628075Possibly a fitNot yet recruiting

Wide-body PET/CT imaging for large vessel vasculitis

Large Vessel VasculitisTakayasu ArteritisGiant Cell Arteritis (GCA)

Part of Brain & nervous system, Heart & circulation, Immune system & allergy, Skin clinical trials.

This study tests a new type of PET/CT scanner that takes images of a larger area of the body to better see inflammation in the blood vessels in people with large vessel vasculitis (LVV). It aims to improve how doctors detect and monitor this condition.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
18 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You must be at least 18 years old.
  • You must have been recently diagnosed with large vessel vasculitis (LVV).
  • You must be able to lie still inside a scanner for the imaging procedure.
  • You must not have started steroids more than 7 days before the scan.
  • If you have diabetes, your blood sugar must be well controlled (below 11 mmol/L).
  • If you have kidney issues, your kidney function must be adequate (eGFR ≥ 30).

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06824714Recruiting
Predicting blood vessel damage in large vessel vasculitis

This study uses PET and MRA scans to predict damage to large blood vessels in people who have or may have large vessel vasculitis (LVV). It aims to find at-risk patients early so they can get better care. You'll need to be willing to have both scans and come back for long-term check-ups.

Nanjing, Jiangsu
NCT06887062Recruiting· Phase 2
Testing dapagliflozin and bosentan for large vessel vasculitis

This trial tests two drugs, dapagliflozin and bosentan, to see if they help people with large vessel vasculitis who have been in remission for at least 6 months. The goal is to prevent flares and improve blood vessel health.

Edinburgh
NCT06335888Recruiting· Phase 2
Testing a new imaging agent for large vessel vasculitis

This study tests a special radioactive tracer, 18F-AzaFol, to see if it can help diagnose large vessel vasculitis, a type of inflammation in the arteries. The results will be compared with standard FDG PET/CT scans.

Bern
NCT07151521Recruiting
FAPI PET/CT in ANCA vasculitis with lung disease

This study uses a special PET/CT scan (called FAPI) to look at inflammation in people with ANCA-associated vasculitis and interstitial lung disease. It may help doctors see how active the disease is and guide treatment.

Shanghai
NCT07604207Not yet recruiting· Early Phase 1
Imaging heart and blood vessel health

This study uses advanced imaging (PET scans) to look at how well blood vessels and organs are working, which may help understand heart disease. It is open to people with heart disease and also to healthy volunteers.

NCT07063043Recruiting
A study using a new scan to look at heart disease

This trial is testing a new imaging method (68Ga-FAPI PET/CMR) to better see and understand heart problems. It might help doctors diagnose or monitor conditions like heart failure or inflammation.

Shanghai, Shanghai Municipality

Hear when a new Large Vessel Vasculitis trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.